遗传性综合征与肾细胞癌:放射科医生需要知道什么
本综述概述美国国家综合癌症网络(NCCN)认可的七种遗传性肾细胞癌综合征的遗传方式、流行病学与临床病理特征,并讨论部分综合征中肾细胞癌的影像诊断难点,包括在结节性硬化症中鉴别肾细胞癌与乏脂型血管平滑肌脂肪瘤、在遗传性乳头状肾癌中鉴别乳头状肾细胞癌与出血性囊肿、在Birt-Hogg-Dubé综合征中鉴别嫌色细胞肾细胞癌与嗜酸细胞瘤。放射科医生常是首先识别提示潜在遗传综合征的临床病理特征者,对多学科管理至关重要。
要点
- 七种遗传性肾细胞癌综合征包括结节性硬化症、VHL、HLRCC、HPRC、BHDS、SDH缺陷型肾细胞癌/遗传性副神经节瘤-嗜铬细胞瘤综合征及BAP1肿瘤易感综合征。
- 结节性硬化症中需鉴别肾细胞癌与更常见的乏脂型血管平滑肌脂肪瘤。
- HPRC中需鉴别乳头状肾细胞癌与出血性囊肿;BHDS中需鉴别嫌色细胞肾细胞癌与嗜酸细胞瘤。
核心结论
- 放射科医生常是首先识别提示潜在遗传综合征的临床病理特征者,识别这些模式对于及时启动遗传学评估、指导保留肾单位干预决策以及为患者及其高危家庭成员建立适当监测至关重要。
研究设计与样本
- 综述,总结美国国家综合癌症网络(NCCN)认可的七种遗传性肾细胞癌综合征的遗传方式、流行病学及临床病理特征,并讨论相关影像诊断挑战。
关键影像表现/征象
- 结节性硬化症中肾细胞癌需与更常见的乏脂型血管平滑肌脂肪瘤鉴别。
- HPRC中乳头状肾细胞癌需与出血性囊肿鉴别。
- BHDS中嫌色细胞肾细胞癌需与嗜酸细胞瘤鉴别。
临床应用与阅片要点
- 放射科医生常首先识别提示潜在遗传综合征的临床病理特征,应推动及时遗传学评估。
- 识别遗传性肾细胞癌综合征的影像模式有助于指导保留肾单位干预决策。
- 识别这些模式有助于为患者及其高危家庭成员建立适当监测。
- 放射基因组学和人工智能的进展有望进一步改进无创诊断和个体化患者管理。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
Hereditary renal cell carcinoma (RCC) accounts for approximately 5-8% of all renal cancers. This review provides a comprehensive overview of the seven hereditary RCC syndromes recognized by the National Comprehensive Cancer Network: Tuberous Sclerosis Complex (TSC), Von Hippel-Lindau (VHL), Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC), Hereditary Papillary Renal Carcinoma (HPRC), Birt-Hogg-Dubé syndrome (BHDS), Succinate dehydrogenase (SDH)-deficient RCC/Hereditary Paraganglioma/Pheochromocytoma (PGL/PCC) syndrome, and BAP1 tumor predisposition syndrome (BAP1-TPDS). For each syndrome, the underlying inheritance, epidemiology, and clinicopathologic features of their associated RCCs are detailed. Furthermore, radiographic challenges faced in the diagnosis of RCC in some of these syndromes are discussed, including differentiating RCC from the more common lipid-poor AML in TSC, distinguishing papillary RCC from hemorrhagic cysts in HPRC, and discerning chromophobe RCC from oncocytomas in BHDS. Radiologists are integral to the multidisciplinary management of hereditary RCC, as they are often the first to identify clinicopathologic features suggestive of an underlying genetic syndrome. Recognizing these patterns is crucial for prompting timely genetic evaluation, guiding decisions for nephron-sparing interventions, and establishing appropriate surveillance for patients and their at-risk family members. Advances in radiogenomics and artificial intelligence hold promise for further refining non-invasive diagnosis and personalizing patient care.
引用
- Charbel C, Withey SJ, Serrao E, et al. Hereditary syndromes and RCC: what radiologists need to know. Abdom Radiol (NY). 2025. PMID: 41284030. doi:10.1007/s00261-025-05302-2
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。